Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Idiopathic Parkinson's Disease
Clinical trial NCT02611167 · COMPLETED
Trial details
- NCT number
- NCT02611167
- Sponsor
- The University of Texas Health Science Center, Houston
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-01
- Primary completion
- 2019-09-18
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.